- 专利标题： Nitrogen-containing heterocyclic compound
-
申请号： US15608565申请日： 2017-05-30
-
公开(公告)号： US09789084B2公开(公告)日： 2017-10-17
- 发明人: Masami Yamada , Shinkichi Suzuki , Takahiro Sugimoto , Minoru Nakamura , Hiroki Sakamoto , Makoto Kamata
- 申请人： Takeda Pharmaceutical Company Limited
- 申请人地址： JP Osaka
- 专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人地址： JP Osaka
- 代理机构： Hamre, Schumann, Mueller & Larson, P.C.
- 优先权： JP2014-089585 20140423
- 主分类号： C07D209/46
- IPC分类号： C07D209/46 ; C07D401/10 ; C07D401/14 ; C07D403/04 ; C07D403/10 ; C07D405/04 ; C07D405/14 ; A61K31/4035 ; A61K31/4406 ; A61K31/045 ; C07D471/04
摘要：
The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like.The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.
公开/授权文献
- US20170258764A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND 公开/授权日：2017-09-14
信息查询
